Erdei A
Basel Institute for Immunology, Switzerland.
J Immunol. 1990 Sep 15;145(6):1754-60.
Different cells and cell lines of murine origin were tested for their capacity to bind the C subcomponent C1q by using biotinylated human C1q and streptavidin-FITC. Cytofluorometric analysis of splenocytes and thymocytes shows that the majority of C1q-reactive cells reside in the population of B cells and macrophages. There is a significant difference in the C1q-binding capacity of in vitro activated cells; although more than half of the B cell blasts bind the C subcomponent, T cell blasts are virtually negative. It is shown that pre-B lymphomas and cell lines of myeloid origin bind C1q strongly (90 to 98%), whereas in the case of mature B cell lymphomas, plasmocytomas, and the tested T cell lines, the percentage of C1q binding cells varies from 0 to 56. C1q affinity chromatography of the detergent extracts from P388D1 and WEHI-3 cells followed by SDS-PAGE of the eluted proteins under reducing conditions reveals a band at approximately 80 kDa. Analysis of splenocytes shows two additional minor C1q-binding molecules with apparent molecular masses of 50 and 45 kDa, whereas in the case of B cell blasts three bands of similar density are seen at approximately 95, 50 and 45 kDa. C1q-receptors of murine cells are shown to be antigenically related to their human counterpart, because a polyclonal antibody (266A) raised against the human C1q receptor reacts with them.
利用生物素化的人C1q和链霉亲和素-异硫氰酸荧光素,对不同的源自小鼠的细胞和细胞系结合补体C亚成分C1q的能力进行了检测。对脾细胞和胸腺细胞的细胞荧光分析表明,大多数C1q反应性细胞存在于B细胞和巨噬细胞群体中。体外活化细胞的C1q结合能力存在显著差异;虽然超过一半的B细胞母细胞能结合C亚成分,但T细胞母细胞实际上呈阴性。结果显示,前B淋巴瘤和髓系来源的细胞系能强烈结合C1q(90%至98%),而对于成熟B细胞淋巴瘤、浆细胞瘤和所检测的T细胞系,C1q结合细胞的百分比在0至56之间变化。对P388D1和WEHI-3细胞的去污剂提取物进行C1q亲和层析,然后在还原条件下对洗脱蛋白进行SDS-PAGE分析,发现在约80 kDa处有一条带。对脾细胞的分析显示,还有另外两个较小的C1q结合分子,表观分子量分别为50 kDa和45 kDa,而在B细胞母细胞中,在约95 kDa、50 kDa和45 kDa处可见三条密度相似的带。已证明小鼠细胞的C1q受体在抗原性上与其人类对应物相关,因为针对人C1q受体产生的多克隆抗体(266A)能与它们发生反应。